Company Overview

Update
Headquarters:
Cambridge
Funding:
$6M
Categories:
Biotechnology
Description:
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.

Detailed Description

Update

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes. The Company’s proprietary production platform OptiDIFF robustly generates human cell types including liver hepatocytes using hIPSC human Induced Pluripotent Stem Cell technology.

Funding Rounds (2) - $6M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    Babraham Research Campus

    Babraham

    Cambridge, CB22 3AT

    GBR

Images (1)

Update
  • 34af3db8775a987af1b74b3d64ae0b31